X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Coins and pills on a scale Mylan CEO Heather Bresch urges companies footing the bill for employee health costs to examine the instances in which plans aren’t steering patients toward the cheapest available treatments. (Image: Shutterstock)

Generic drugmakers are being crushed by the very forces that the Trump administration is counting on to drive down prescription costs.

BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now

Copyright © 2018 ALM Media Properties, LLC. All Rights Reserved.